TrialScientific reports2024

Nebulized enriched heparin improves respiratory parameters in patients with COVID-19: a phase I/II randomized and triple-blind clinical trial.

Vinicius Tadeu Ramos da Silva Grillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.